• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SMARTFREEZE; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SMARTFREEZE; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Lot Number 0033190043
Medical Device Problem Code Gas/Air Leak (2946)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/01/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event or Problem Description
It was reported that during ongoing use there was a leak from the console.The site contacted tech services to notify them that the smartfreeze console was leaking.This was not during a procedure and there was no patient involvement, no injury to any other personal was reported.The issue could not be troubleshooted over the phone so a field service engineer went to the site.Damage to the hose that runs between the n2o tank and the processing plate was identified.Replacement of the hose was required.The console is not expected to be returned as it was serviced on site.
 
Event or Problem Description
It was reported that during ongoing use there was a leak from the console.The site contacted tech services to notify them that the smartfreeze console was leaking.This was not during a procedure and there was no patient involvement, no injury to any other personal was reported.The issue could not be troubleshooted over the phone so a field service engineer went to the site.Damage to the hose that runs between the n2o tank and the processing plate was identified.Replacement of the hose was required.The console is not expected to be returned as it was serviced on site.
 
Additional Manufacturer Narrative
The console was not returned to boston scientific's post marky laboratory for analysis; however, the console was serviced by a field technician.The report from that service call was analyzed and confirmed the allegation of a leak from the console.A hose connecting the n20 tank to the rest of the console was replaced due to a leak.The cause of the issue was traced to component failure due to the deficiencies of the connecting hose.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTFREEZE
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112 5798
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18301132
Report Number2124215-2023-69833
Device Sequence Number11665985
Product Code OAE
UDI-Device Identifier08714729992721
UDI-Public08714729992721
Combination Product (Y/N)N
Initial Reporter CountryCA
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Lot Number0033190043
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 12/01/2023
Supplement Date Received by Manufacturer01/30/2024
Initial Report FDA Received Date12/11/2023
Supplement Report FDA Received Date02/19/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/24/2019
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient SexUnknown
-
-